This ICR is a web-based survey to investigate healthcare providers’ (HCPs’) awareness, perceptions, and beliefs about the benefits and risks of an FDA-approved product that includes a boxed warning as part of its approved prescribing information. This study will strengthen FDA’s understanding of how HCPs may receive, process, and use boxed warning information and identify HCPs’ potential information needs with respect to the topics addressed by a product’s boxed warning. This research will evaluate two treatment scenarios involving an FDA-approved medication or class of medications that include boxed warning information.
The latest form for Healthcare Provider Perception of Boxed Warning Information Survey expires 2023-08-31 and can be found here.
Justification for No Material/Nonsubstantive Change
Supporting Statement B
Supporting Statement A
Approved without change
|No material or nonsubstantive change to a currently approved collection||2020-10-26|
Approved with change
|New collection (Request for a new OMB Control Number)||2020-07-08|
Federal Enterprise Architecture: Health - Health Care Services